Francisella philomiragia sepsis in chronic granulomatous disease

Pediatric Infectious Disease Journal

Volumn 16, Issue 4, 1997, Pages 420-422

  Sicherer, Scott H ^a   Asturias, Edwin J ^a   Winkelstein, Jerry A ^a   Dick, James D ^a   Willoughby, Rodney E ^a  

^a JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

Chronic granulomatous disease; Francisella philomiragia; sepsis

Indexed keywords

ADULT; ARTICLE; CASE REPORT; FRANCISELLA; GRANULOMATOSIS; HUMAN; MALE; PRIORITY JOURNAL; SEPSIS; SPLEEN ABSCESS; THORACOCENTESIS;

ABSCESS; ADULT; FRANCISELLA; GRAM-NEGATIVE BACTERIAL INFECTIONS; GRANULOMATOUS DISEASE, CHRONIC; HUMANS; MALE; SEPSIS; SPLEEN; WATER MICROBIOLOGY;

EID: 0030902642     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006454-199704000-00021     Document Type: Article

References (15)

1. Curnutte JT. Chronic granulomatous disease: the solving of a clinical riddle at the molecular level. Clin Immunol Immunopathol 1993;67:S2-15.
2. Wenger JD, Hollis DG, Weaver RE, et al. Infection caused by Francisella philomiragia (formerly Yersinia philomiragia): a newly recognized human pathogen. Ann Intern Med 1989; 110:888-92.
3. Hollis DG, Weaver RE, Steigerwalt AG, et al. Francisella philomiragia comb. nov. (formerly Yersinia philomiragia) and Francisella tularensis biogroup Novicida (formerly Francisella novicida) associated with human disease. J Clin Microbiol 1989;27:1601-8.
4. Osterhout GJ, Shull VH, Dick JD. Identification of clinical isolates of Gram-negative nonfermentative bacteria by an automated cellular fatty acid identification system. J Clin Microbiol 1991;29:1822-30.
5. Maidek BL, Larsen N, McCaughey MJ, et al. The ribosomal database project. Nucleic Acids Res 1994;22:3485-7.
6. Ursing J, Steigerwalt AG, Brenner DJ. Lack of genetic relatedness between Yersinia philomiragia (the "philomiragia" bacterium) and Yersinia species. Curr Microbiol 1980;4: 231-3.
7. Jantzen K, Berdal BP, Omland T. Cellular and fatty composition of Francisella tularensis. J Clin Microbiol 1979;10:928-30.
8. Quan SF, McManus AG, von Fintel H. Infectivity of tularemia applied to intact skin and ingested drinking water. Science 1956;123:942-3.
9. Tärnvik A. Nature of protective immunity to Francisella tularensis. Rev Infect Dis 1989;11:440-50.
10. Polsinelli T, Meltzer MS, Fortier AH. Nitric oxide-dependent killing of Francisella tularensis by IFN-γ-stimulated murine alveolar macrophages. J Immunol 1994;153:1238-45.
11. Fortier AH, Polsinelli T, Green SJ, Nacy CA. Activation of macrophages for destruction of Francisella tularensis: identification of cytokines, effector cells, and effector molecules. Infect Immun 1992;60:817-25.
12. The International Chronic Granulomatous Disease Cooperative Study Group. A controlled trial of Interferon gamma to prevent infection in chronic granulomatous disease. N Engl J Med 1991;324:509-16.
13. Jensen WI, Owen CR, Jellison WJ. Yersinia philomiragia sp. n., a new member of the Pasteurella group of bacteria, naturally pathogenic for the muskrat (Ondatra zibethica). J Bacteriol 1969;100:1237-41.
14. Seger RA, Hollis DG, Weaver RE, Hitzig WH. Chronic granulomatous disease: Fatal septicemia caused by an unnamed Gram-negative bacterium. J Clin Microbiol 1982;16:821-5.
15. Peerless AG, Liebhaber M, Anderson S, Lehrer RI, Steihm ER. Legionella pneumonia in chronic granulomatous disease. J Pediatr 1986;5:783-5.